Investor Presentation
Logotype for Apollo Hospitals Enterprise Limited

Apollo Hospitals (APOLLOHOSP) Investor Presentation summary

Event summary combining transcript, slides, and related documents.

Logotype for Apollo Hospitals Enterprise Limited

Investor Presentation summary

13 Jun, 2025

India's largest integrated healthcare system

  • Operates 73 hospitals with 10,138 beds and over 10,000 doctors, plus India's largest offline pharmacy network with 6,000+ stores in 1,200+ cities and towns.

  • Extensive retail healthcare network: 264 primary clinics, 183 dental clinics, 72 sugar clinics, 31 birthing centers, 133 dialysis centers, 22 surgery centers, and 2,203 diagnostic collection centers.

  • Recognized for clinical innovation, digital transformation, and a patient-centric, outcomes-driven care model.

  • Built a trusted brand synonymous with quality, supported by significant government recognition and successful partnerships.

  • Created unmatched consumer insights and shareholder value, with a 6x increase in market capitalization over the last decade.

Financial and operational performance

  • FY24 consolidated revenue reached $2.29 billion, with a 16% CAGR since FY13; healthcare services and pharmacy segments grew at 14% and 20% CAGR, respectively.

  • Q2FY25 consolidated revenue grew 15% YoY to 55,893 mio, EBITDA up 30% to 8,155 mio, and PAT up 63% to 3,788 mio.

  • H1FY25 consolidated revenue rose 15% YoY to 106,749 mio, EBITDA up 31% to 14,906 mio, and PAT up 71% to 6,840 mio.

  • Healthcare services maintained strong margins (24.9% in Q2FY25), with occupancy at 73% and ARPOB up 3% YoY.

  • Return on capital employed (ROCE) for healthcare services at 26.1% and pharmacy distribution at 31.5% as of March 2024.

Segment highlights and expansion

  • Apollo Health & Lifestyle Ltd (AHLL) revenue grew 14% YoY in Q2FY25, with diagnostics and specialty care showing strong margin improvements.

  • Apollo HealthCo (omnichannel pharmacy) revenue grew 17% YoY in Q2FY25, with PAT turning positive due to cost optimization and operational growth.

  • Advent International invested INR 1,732 crs in Apollo HealthCo, with a phased merger of Keimed to create India's leading integrated pharmacy distribution business.

  • Expansion plans include new hospitals and brownfield projects in major metros and Tier 1 cities, targeting over 3,500 new beds in the next 3-4 years.

  • Digital platform Apollo 24/7 serves 36 million+ registered users, with 6,228 pharmacies and 14,500+ daily virtual consultations.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more